A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness

Psychiatry Research

Volumn 188, Issue 1, 2011, Pages 109-114

  Kreyenbuhl, Julie ^a,b   Leith, Jaclyn ^a   Medoff, Deborah R ^a,b   Fang, LiJuan ^a   Dickerson, Faith B ^c   Brown, Clayton H ^a,b   Goldberg, Richard W ^a,b   Potts, Wendy ^a   Dixon, Lisa B ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Education and Clinical Center   (United States)

^c SHEPPARD PRATT HEALTH SYSTEM   (United States)

Author keywords

Mood disorder; Schizophrenia; Self management

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BLOOD GLUCOSE MONITORING; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SELF CARE; SELF REPORT; TREATMENT REFUSAL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 79956004855     PISSN: 01651781     EISSN: 01651781     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.03.013     Document Type: Article

References (38)

1. Brown S., Inskip H., Barraclough B. Causes of the excess mortality of schizophrenia. The British Journal of Psychiatry 2000, 177:212-217.
2. Byerly M.J., Nakonezny P.A., Lescouflair E. Antipsychotic medication adherence in schizophrenia. The Psychiatric Clinics of North America 2007, 30:437-452.
3. Byerly M.J., Thompson A., Carmody T., Bugno R., Erwin T., Kashner M., Rush A.J. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services 2007, 58:844-847.
4. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006, 3(2):1-14.
5. Depp C.A., Cain A.E., Palmer B.W., Moore D.J., Eyler L.T., Lebowitz B.D., Patterson T.L., Jeste D.V. Assessment of medication management ability in middle-aged and older adults with bipolar disorder. Journal of Clinical Psychopharmacology 2008, 28:225-229.
6. Dickinson D., Gold J.M., Dickerson F.B., Medoff D., Dixon L.B. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics 2008, 49:123-131.
7. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50years of research. Medical Care 2004, 42:200-209.
8. Dixon L.B., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin 2000, 26:903-912.
9. Dixon L.B., Kreyenbuhl J.A., Dickerson F.B., Donner T.W., Brown C.H., Wohlheiter K., Postrado L., Goldberg R.W., Fang L., Marano C., Messias E. A comparison of Type 2 diabetes outcomes among persons with and without severe mental illness. Psychiatric Services 2004, 55:892-900.
10. Dixon L.B., Adler D.A., Berlant J.L., Dulit R.A., Goldman B., Hackman A.L., Oslin D.W., Siris S.G., Sonis W.A., Valenstein M. Psychiatrists and primary caring: what are our boundaries of responsibility?. Psychiatric Services 2007, 58:600-602.
11. Dolder C.R., Lacro J.P., Jeste D.V. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosomatic Medicine 2003, 65:156-162.
12. Dolder C.R., Furtek K., Lacro J.P., Jeste D.V. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics 2005, 46:135-141.
13. Grant R.W., Devita N.G., Singer D.E., Meigs J.B. Polypharmacy and medication adherence in patients with Type 2 diabetes. Diabetes Care 2003, 26:1408-1412.
14. Hays R.D., Kravitz R.L., Mazel R.M., Sherbourne C.D., DiMatteo M.R., Rogers W.H., Greenfield S. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. Journal of Behavioral Medicine 1994, 17:347-360.
15. Heinrichs R.W., Goldberg J.O., Miles A.A., McDermid Vaz S. Predictors of medication competence in schizophrenia patients. Psychiatry Research 2008, 157:47-52.
16. Hill-Briggs F., Gary T.L., Bone L.R., Hill M.N., Levine D.M., Brancati F.L. Medication adherence and diabetes control in urban African Americans with Type 2 diabetes. Health Psychology 2005, 24:349-357.
17. Himelhoch S., Brown C., Walkup J., Chander G., Korthius P.T., Afful J., Gebo K. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS 2009, 23:1735-1742.
18. Ho P.M., Rumsfeld J.S., Masoudi F.A., McClure D.L., Plomondon M.E., Steiner J.F., Magid D.J. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine 2006, 166:1836-1841.
19. Horne R., Weinman J., Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health 1999, 14:1-24.
20. Jeste S.D., Patterson T.L., Palmer B.W., Dolder C.R., Goldman S., Jeste D.V. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research 2003, 63:49-58.
21. Jónsdóttir H., Friis S., Horne R., Pettersen K.I., Reikvam A., Andreassen O.A. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatrica Scandinavica 2009, 119:78-84.
22. Krapek K., King K., Warren S.S., George K.G., Caputo D.A., Mihelich K., Holst E.M., Nichol M.B., Shi S.G., Livengood K.B., Walden S., Lubowski T.J. Medication adherence and associated hemoglobin A1c in Type 2 diabetes. The Annals of Pharmacotherapy 2004, 38:1357-1362.
23. Krein S.L., Bingham C.R., McCarthy J.F., Mitchinson A., Payes J., Valenstein M. Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatric Services 2006, 57:1016-1021.
24. Kreyenbuhl J., Dixon L.B., McCarthy J.F., Soliman S., Ignacio R.V., Valenstein M. Does adherence to medications for Type 2 diabetes differ between individuals with versus without schizophrenia?. Schizophrenia Bulletin 2010, 36:428-435.
25. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. The Journal of Clinical Psychiatry 2002, 63:892-909.
26. Lau D.T., Nau D.P. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with Type 2 diabetes. Diabetes Care 2004, 27:2149-2153.
27. Osby U., Correia N., Brandt L., Ekbom A., Sparen P. Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophrenia Research 2000, 45:21-28.
28. Patterson T.L., Lacro J., McKibbin C.L., Moscona S., Hughs T., Jeste D.V. Medication management ability assessment: Results from a performance-based measure in older outpatients with schizophrenia. Journal of Clinical Psychopharmacology 2002, 22:11-19.
29. Piette J.D., Heisler M., Ganoczy D., McCarthy J.F., Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatric Services 2007, 58:207-212.
30. Randolph C. RBANS Manual: Repeatable Battery for the Assessment of Neuropsychological Status 1998, Psychological Corporation, San Antonio.
31. Rozenfeld Y., Hunt J.S., Plauschinat C., Wong K.S. Oral antidiabetic medication adherence and glycemic control in managed care. The American Journal of Managed Care 2008, 14:71-75.
32. Schectman J.M., Nadkarni M.M., Voss J.D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002, 25:1015-1021.
33. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care 2005, 43:521-530.
34. Stuart B.C., Simoni-Wastila L., Zhao L., Lloyd J.T., Doshi J.A. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care 2009, 32:647-649.
35. Svarstad B.L., Chewning B.A., Sleath B.L., Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Education and Counseling 1999, 37:113-124.
36. Velligan D.I., Wang M., Diamond P., Glahn D.C., Castill o.D., Bendle S., Lam Y.W., Ereshefsky L., Miller A.L. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services 2007, 58:1187-1192.
37. Weiss A.P., Henderson D.C., Weilburg J.B., Goff D.C., Meigs J.B., Cagliero E., Grant R.W. Treatment of cardiac risk factors among patients with schizophrenia and diabetes. Psychiatric Services 2006, 57:1145-1152.
38. Wooldridge K.L., Wallston K.A., Graber A.L., Brown A.W., Davidson P. The relationship between health beliefs, adherence, and metabolic control of diabetes. The Diabetes Educator 1992, 18:495-500.